Changing Treatment Landscape in Soft Tissue Sarcoma

Saketh Guntupalli, MD, and Victor Villalobos, MD, PhD, discuss the emergence of olaratumab as an option for patients with advanced, unresectable soft tissue sarcoma, and how it has impacted the treatment landscape.

• categorie